These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

398 related articles for article (PubMed ID: 34834304)

  • 21. Engineered Cell Membrane-Camouflaged Nanomaterials for Biomedical Applications.
    Guan X; Xing S; Liu Y
    Nanomaterials (Basel); 2024 Feb; 14(5):. PubMed ID: 38470744
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recent Advances in the Development of Drug Delivery Applications of Magnetic Nanomaterials.
    Pusta A; Tertis M; Crăciunescu I; Turcu R; Mirel S; Cristea C
    Pharmaceutics; 2023 Jul; 15(7):. PubMed ID: 37514058
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Silica-Based Nanoparticles for Biomedical Applications: From Nanocarriers to Biomodulators.
    Yang Y; Zhang M; Song H; Yu C
    Acc Chem Res; 2020 Aug; 53(8):1545-1556. PubMed ID: 32667182
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recent advancement of bioinspired nanomaterials and their applications: A review.
    Wu G; Hui X; Hu L; Bai Y; Rahaman A; Yang XF; Chen C
    Front Bioeng Biotechnol; 2022; 10():952523. PubMed ID: 36159672
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mesenchymal stem cell-based drug delivery strategy: from cells to biomimetic.
    Wu HH; Zhou Y; Tabata Y; Gao JQ
    J Control Release; 2019 Jan; 294():102-113. PubMed ID: 30553849
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Smart blood cell and microvesicle-based Trojan horse drug delivery: Merging expertise in blood transfusion and biomedical engineering in the field of nanomedicine.
    Wu YW; Goubran H; Seghatchian J; Burnouf T
    Transfus Apher Sci; 2016 Apr; 54(2):309-18. PubMed ID: 27179926
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tumor Microenvironment-Specific Functional Nanomaterials for Biomedical Applications.
    Zhao L; Liu H; Xing Y; Wang R; Cheng Z; Lv C; Lv Z; Yu F
    J Biomed Nanotechnol; 2020 Sep; 16(9):1325-1358. PubMed ID: 33419489
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Design principles of bioinspired interfaces for biomedical applications in therapeutics and imaging.
    Shih CP; Tang X; Kuo CW; Chueh DY; Chen P
    Front Chem; 2022; 10():990171. PubMed ID: 36405322
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biomolecules-conjugated nanomaterials for targeted cancer therapy.
    Wang J; Wang TT; Gao PF; Huang CZ
    J Mater Chem B; 2014 Dec; 2(48):8452-8465. PubMed ID: 32262204
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Melanin-based nanomaterials: The promising nanoplatforms for cancer diagnosis and therapy.
    Hong ZY; Feng HY; Bu LH
    Nanomedicine; 2020 Aug; 28():102211. PubMed ID: 32320736
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Engineered Polymer Nanoplatforms for Targeted Tumor Cells and Controlled Release Cargos to Enhance Cancer Treatment.
    Wang Z; Tang L; Mu Q; Che S; Sun Y; Bai L; Luo Y; Yang Y; Yu M; Yu Z
    Curr Med Chem; 2021; 28(31):6395-6410. PubMed ID: 33634752
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Research Progress of Neutrophil-Mediated Drug Delivery Strategies for Inflammation-Related Disease.
    Zhao Y; Zhang H; Zhang Q; Tao H
    Pharmaceutics; 2023 Jul; 15(7):. PubMed ID: 37514067
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nanosize drug delivery system.
    Mukherjee B
    Curr Pharm Biotechnol; 2013; 14(15):1221. PubMed ID: 25106648
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Advances of blood cell-based drug delivery systems.
    Sun Y; Su J; Liu G; Chen J; Zhang X; Zhang R; Jiang M; Qiu M
    Eur J Pharm Sci; 2017 Jan; 96():115-128. PubMed ID: 27496050
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hybrid cell membrane-coated nanoparticles: A multifunctional biomimetic platform for cancer diagnosis and therapy.
    Chen HY; Deng J; Wang Y; Wu CQ; Li X; Dai HW
    Acta Biomater; 2020 Aug; 112():1-13. PubMed ID: 32470527
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biomineralization: An Opportunity and Challenge of Nanoparticle Drug Delivery Systems for Cancer Therapy.
    Wang W; Liu X; Zheng X; Jin HJ; Li X
    Adv Healthc Mater; 2020 Nov; 9(22):e2001117. PubMed ID: 33043640
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Leveraging Engineering of Cells for Drug Delivery.
    Chen Z; Hu Q; Gu Z
    Acc Chem Res; 2018 Mar; 51(3):668-677. PubMed ID: 29446615
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypoxia-modulatory nanomaterials to relieve tumor hypoxic microenvironment and enhance immunotherapy: Where do we stand?
    Yuan CS; Deng ZW; Qin D; Mu YZ; Chen XG; Liu Y
    Acta Biomater; 2021 Apr; 125():1-28. PubMed ID: 33639310
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nanoparticles for Cancer Targeting: Current and Future Directions.
    Swain S; Sahu PK; Beg S; Babu SM
    Curr Drug Deliv; 2016; 13(8):1290-1302. PubMed ID: 27411485
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biomimetic camouflage delivery strategies for cancer therapy.
    Asrorov AM; Gu Z; Li F; Liu L; Huang Y
    Nanoscale; 2021 May; 13(19):8693-8706. PubMed ID: 33949576
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.